Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Humanin

HN, S14G-Humanin

Quick Stats
Studies 491
Trials 100
Score 2
2025 pubmed 5 citations

SHLP6: a novel NLRP3 and Cav1 modulating agent in Cu-induced oxidative stress and neurodegeneration.

Thamarai Kannan. H H; Umapathy. Suganiya S; Pan. Ieshita I

Key Findings

  • SHLP-6 at 40 µg/mL raised zebrafish survival to 85% and improved heart rate
  • It lowered reactive oxygen species by up to 74% and increased antioxidant enzymes (SOD, CAT, GSH)
  • Gene expression showed reduced inflammation markers and higher anti‑inflammatory IL‑10

Practical Outcomes

  • The study suggests SHLP-6 could be a powerful antioxidant and neuroprotective agent, but because it’s only been tested in zebrafish, there’s no clear human dosing or protocol yet. Biohackers should view this as early‑stage evidence and wait for human trials before trying it.

Summary

A tiny protein called SHLP-6, which is similar to the anti‑aging peptide humanin, helped zebrafish larvae survive copper‑induced damage. It cut harmful oxidative stress, boosted natural antioxidant enzymes, and improved movement and brain‑related markers, but the work was done only in fish, not people.

Abstract

Copper sulfate exposure induces oxidative stress by triggering excessive reactive oxygen species (ROS) production, leading to inflammatory responses, neuroinflammation, and cellular dysfunction. Small humanin-like peptide-6 (SHLP-6), a mitochondria-derived peptide with anti-aging and anti-cancer properties, has not been explored for its protective effects against copper sulfate toxicity. This study investigates the antioxidant, anti-inflammatory, and neuroprotective potential of SHLP-6 in zebrafish larvae exposed to copper sulfate. Zebrafish larvae were exposed to copper sulfate and treated with SHLP-6 at concentrations ranging from 10 to 50 &#x3bc;g/mL. ROS-scavenging activity was assessed using <i>in vitro</i> assays, and enzymatic antioxidant markers, lipid peroxidation, nitric oxide levels, acetylcholine esterase (AChE) activity, and locomotor behavior were evaluated. Additionally, gene expression analysis was performed for inflammatory and antioxidant markers. Treatment with SHLP-6 at 40 &#x3bc;g/mL significantly reduced malformations, improved heart rate (178 bpm), and increased survival rates (85%) in zebrafish larvae. The highest ROS inhibition was observed at 58.7% and 74.3%, while antioxidant enzyme activity was enhanced, with superoxide dismutase (68.3 U/mg), catalase (82.40 U/mg), and reduced glutathione (79.3 U/mg). Lipid peroxidation and nitric oxide levels decreased to 3.86 and 3.41 U/mg, respectively. SHLP-6 improved AChE levels (78.3 U/mg) and locomotor activity (43.53 m distance travelled). SHLP-6 upregulated TNF-&#x3b1; (2.16-fold), NLRP3 (1.78-fold), and COX-2 (0.705-fold), while increasing IL-10 (1.84-fold), suggesting neuroinflammation modulation. Antioxidant gene expression (SOD, CAT, GST, and GSH) was significantly upregulated. These findings indicate SHLP-6's potential as a neuroprotective and antioxidant agent against copper sulfate-induced toxicity.

Study Information

Provider

pubmed

Year

2025

Date

2025-04-01T00:00:00.000Z

DOI

10.3389/fnmol.2025.1553308

Citations

5

References

54